ARTRYA Ltd
Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a suite ifcloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography sca… Read more
ARTRYA Ltd (AYA) - Total Liabilities
Latest total liabilities as of June 2025: AU$2.39 Million AUD
Based on the latest financial reports, ARTRYA Ltd (AYA) has total liabilities worth AU$2.39 Million AUD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
ARTRYA Ltd - Total Liabilities Trend (2019–2025)
This chart illustrates how ARTRYA Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
ARTRYA Ltd Competitors by Total Liabilities
The table below lists competitors of ARTRYA Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Morris State Bancshares Inc
OTCQX:MBLU
|
USA | $1.35 Billion |
|
Ahlatci Dogal Gaz Dagitim Enerji ve Yatirim A.S.
IS:AHGAZ
|
Turkey | TL36.93 Billion |
|
Lanzhou Zhuangyuan Pasture Co Ltd
SHE:002910
|
China | CN¥1.28 Billion |
|
AudioCodes Ltd
NASDAQ:AUDC
|
USA | $151.86 Million |
|
VIVO Cannabis Inc
PINK:ABCCF
|
USA | $15.93 Million |
|
Albatron Technology Co Ltd
TWO:5386
|
Taiwan | NT$701.16 Million |
|
Shenyang Cuihua Gold and Silver Jewelry Co Ltd
SHE:002731
|
China | CN¥4.31 Billion |
|
Weihai Baihe Biology Technological Co. Ltd.
SHG:603102
|
China | CN¥196.93 Million |
Liability Composition Analysis (2019–2025)
This chart breaks down ARTRYA Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 8.27 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 5.47 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.11 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.10 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ARTRYA Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ARTRYA Ltd (2019–2025)
The table below shows the annual total liabilities of ARTRYA Ltd from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$2.39 Million | +8.11% |
| 2024-06-30 | AU$2.21 Million | -12.80% |
| 2023-06-30 | AU$2.53 Million | -21.59% |
| 2022-06-30 | AU$3.23 Million | +175.98% |
| 2021-06-30 | AU$1.17 Million | +620.51% |
| 2020-06-30 | AU$162.39K | +163.73% |
| 2019-06-30 | AU$61.57K | -- |